Back to Search
Start Over
1702 Patients enrolled in the accelerating medicines partnership (AMP) RA/SLE network with isolated renal disease report minimal quality of life impairment on PROMIS-29 compared to patients with extrarenal symptoms
- Source :
- Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
- Publication Year :
- 2022
- Publisher :
- BMJ Publishing Group, 2022.
- Subjects :
- Immunologic diseases. Allergy
RC581-607
Subjects
Details
- Language :
- English
- ISSN :
- 20538790
- Volume :
- 9
- Issue :
- Suppl 3
- Database :
- Directory of Open Access Journals
- Journal :
- Lupus Science and Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.725266efe07742e192df8a3a575d5305
- Document Type :
- article
- Full Text :
- https://doi.org/10.1136/lupus-2022-lupus21century.101